Advertisement

Here's Why Gilead Sciences Is More Than Just a COVID-19 Play

Here's Why Gilead Sciences Is More Than Just a COVID-19 Play

Despite its robust HIV portfolio, promising COVID-19 therapeutic, and solid dividend yield, this stock is still a bargain today.